Results 151 to 160 of about 7,804 (207)

Inactivated poliovirus vaccine following oral poliovirus vaccine cessation.

Releve epidemiologique hebdomadaire, 2006
openaire   +1 more source

Aluminium adjuvants in vaccines and potential health effects: systematic review.

BMJ
Doyon-Plourde P, Chong J, Abrams EM, Pless R, Young K, Tunis M, Zafack J.   +6 more
europepmc   +1 more source

Intestinal immunity induced by inactivated poliovirus vaccine

Vaccine, 1987
In order to detect any intestinal immunity against poliovirus infection induced by parenteral vaccination with inactivated poliovirus vaccine (IPV), experiments were conducted in monkeys (Macaca radiata). All animals were seronegative (antibody not detected at 1:2 dilution of serum) before investigation. Sixteen monkeys were vaccinated with three doses
R, Selvakumar, T J, John
openaire   +3 more sources

Some of the next articles are maybe not open access.

Related searches:

Inactivated poliovirus vaccine: past and present experience

Vaccine, 1996
Many countries have made use of inactivated poliovirus vaccine (IPV) in their national poliovirus control programs since 1955. Until 1961 IPV was the only vaccine available for the control of poliovirus, but subsequently many countries opted to use the Sabin attenuated poliovirus vaccine (OPV), which was perceived as more effective in preventing ...
Luis Barreto, Stanley Plotkin, S Plotkin   +2 more
exaly   +3 more sources

World wide experience with inactivated poliovirus vaccine

Vaccine, 2008
As part of the global poliovirus eradication strategy, oral poliovirus vaccine (OPV) has successfully contributed to reduce polio incidence rates globally. However, because of the OPV-related risks of vaccine associated paralytic poliomyelitis (VAPP) and vaccine-derived polioviruses (VDPVs) OPV cessation is required in order to achieve complete ...
Marie-Claude, Bonnet, Anil, Dutta
exaly   +3 more sources

Modeling the Potential Role of Inactivated Poliovirus Vaccine to Manage the Risks of Oral Poliovirus Vaccine Cessation

Journal of Infectious Diseases, 2014
Background: The Global Polio Eradication Initiative plans to stop all oral poliovirus vaccine (OPV) after wild poliovirus eradication, starting with serotype 2.
Radboud J Duintjer Tebbens, Kimberly M Thompson, Duintjer Tebbens Radboud J   +2 more
exaly   +3 more sources

A Randomized Phase 4 Study of Immunogenicity and Safety After Monovalent Oral Type 2 Sabin Poliovirus Vaccine Challenge in Children Vaccinated with Inactivated Poliovirus Vaccine in Lithuania [PDF]

Journal of Infectious Diseases, 2021
BACKGROUND: Understanding immunogenicity and safety of monovalent type 2 oral poliovirus vaccine (mOPV2) in inactivated poliovirus vaccine (IPV)-immunized children is of major importance in informing global policy to control circulating vaccine-derived ...
Ananda S Bandyopadhyay, Chris Gast, Elizabeth B Brickley   +2 more
exaly   +2 more sources

Impact of inactivated poliovirus vaccine on mucosal immunity: implications for the polio eradication endgame [PDF]

Expert Review of Vaccines, 2015
The polio eradication endgame aims to bring transmission of all polioviruses to a halt. To achieve this aim, it is essential to block viral replication in individuals via induction of a robust mucosal immune response. Although it has long been recognized
Edward P K Parker, Natalie A Molodecky, Margarita Pons-Salort   +2 more
exaly   +2 more sources